Inibidores de bomba protônica aumentam o risco geral de desenvolver infecções bacterianas em pacientes com cirrose

Lázaro-Pacheco, Illce B; Servín-Caamaño, Alfredo I; Pérez-Hernández, José L; Rojas-Loureiro, Gabriela; Servín-Abad, Luis; Tijera, Fátima Higuera-De La.
Arq. gastroenterol ; 55(1): 28-32, Apr.-Mar. 2018. tab, graf
Artículo en Inglés | LILACS | ID: biblio-888235

Documentos relacionados

  1. Hospital-Level Care at Home for Patients with Cirrhosis.
  2. Differences in the pattern and cost of hospital care between Indigenous and non-Indigenous Australians with cirrhosis: an exploratory study.
  3. Geographic disparities in access to liver transplant for advanced cirrhosis: Time to ring the alarm!
  4. Appropriate and Potentially Inappropriate Medication Use in Decompensated Cirrhosis.
  5. Healthcare Resource Utilization and Goals of Care Discussions in Patients with Cirrhosis and Acute Kidney Injury.
  6. Current investigations for liver fibrosis treatment: between repurposing the FDA-approved drugs and the other emerging approaches.
  7. The 3-month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis.
  8. Patients With Moderate to Severe Liver Cirrhosis Have Significantly Higher Short-Term Complication Rates Following Total Knee Arthroplasty: A Retrospective Cohort Study.
  9. The Quality and Outcomes of Care Provided to Patients with Cirrhosis by Advanced Practice Providers.
  10. Critical care outcomes in decompensated cirrhosis: a United States national inpatient sample cross-sectional study.